Back
Eastman Chemical 10K Form
Sell
40
EMN
Eastman Chemical
Last Price:
$91.71
Seasonality Move:
3.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-26 | 10Q | EMN/Eastman Chemical Quarterly |
2024-02-14 | 10K | EMN/Eastman Chemical Annual |
2023-10-27 | 10Q | EMN/Eastman Chemical Quarterly |
2023-07-28 | 10Q | EMN/Eastman Chemical Quarterly |
2023-04-28 | 10Q | EMN/Eastman Chemical Quarterly |
2023-02-15 | 10K | EMN/Eastman Chemical Annual |
Receive EMN News And Ratings
See the #1 stock for the next 7 days that we like better than EMN
EMN Financial Statistics
Sales & Book Value
Annual Sales: | $9.2B |
---|---|
Cash Flow: | $275M |
Price / Cash Flow: | 18.26 |
Annual Sales: | $48.78 |
Price / Book: | 1.88 |
Profitability
EPS (TTM): | 7.47000 |
---|---|
Net Income (TTM): | $885M |
Gross Margin: | $2.1B |
Return on Equity: | 15.81% |
Return on Assets: | 5.98% |
Eastman Chemical Earnings Forecast
Key Eastman Chemical Financial Ratios
-
The Gross Profit Margin over the past 31 years for EMN is 22.38%.
-
The Selling, General & Administrative Expenses for EMN have been equal to 8.34% of Gross Profit Margin.
-
The Research & Development expenses have been 2.60% of Revenue.
-
The Interest Expense is 25.17% of Operating Income.
-
The Net Earning history of EMN is 9.71% of Total Revenues.
-
Per Share Earnings over the last 31 years have been positive in 16 years.
Eastman Chemical Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Chemicals |
Sector: | Materials |
Current Symbol: | EMN |
CUSIP: | 277432 |
Website: | eastman.com |
Debt
Debt-to-Equity Ratio: | 0.89 |
---|---|
Current Ratio: | 1.52 |
Quick Ratio: | 0.75 |
Price-to-Earnings
Trailing P/E Ratio: | 12.25 |
---|---|
Forward P/E Ratio: | 10.64 |
EMN Technical Analysis vs Fundamental Analysis
Sell
40
Eastman Chemical (EMN)
is a Sell
Is Eastman Chemical a Buy or a Sell?
-
Eastman Chemical stock is rated a SellThe current Eastman Chemical [EMN] share price is $91.76. The Score for EMN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.